Global regulators urge continuation of COVID-19 vaccine trials for longer-term safety and efficacy follow-up Read more
Phase 3 COVID 19 clinical trials to be designed with stringent success criteria: International Regulators Read more
73 per cent doctors cite ‘antiviral agents’ as most effective therapy for treating COVID-19: Course5 Intelligence report Read more
Medicines regulators allow vaccines in market fulfilling highest standards of safety, efficacy, quality: International regulators Read more
ACE inhibitors, ARBs have not shown effect of these medicines on risk of becoming infected with COVID-19: EMA Read more